Latin America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Latin America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

ID: 6182 | Pages: 145 | April 2018 | Region: Latin America


Latin America Schizoaffective Disorders Treatment Market was worth USD xx billion in 2018 and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2023. Schizoaffective Disorder is a mental disorder which is characterized by deregulated emotions and thought processes and. The diagnosis is made when the person has features of both a mood disorder—either bipolar disorder or depression, and schizophrenia but does not meet the diagnostic criteria for either alone strictly. The bipolar type is distinguished by symptoms of hypomania, mania, or mixed episode; the depressive type only by symptoms of depression. Common symptoms of the disorder include paranoid delusions, hallucinations, and disorganized thinking and speech. The onset of symptoms usually begins in young times of adulthood, presently with an uncertain lifetime prevalence since the disorder was redefined in DSM-IV.  Diagnosis is based on the person's reported experiences observed behaviour.

Neurobiology, genetics, early and current environment, social, behavioural, and experiential components appear to be important contributory factors; some prescription and recreational drugs may worsen or cause symptoms. People with schizoaffective disorder are likely to have co-occurring conditions, including substance use disorder and anxiety disorders. Social problems such as long-term unemployment, homelessness and poverty are common. The average life expectancy of people with the disorder is less than those without it, due to rise of problems related to physical health from an absence of health promoting behaviours including a higher suicide rate and a sedentary lifestyle.

The driving factors of Latin America Schizoaffective Disorders Treatment market are rapidly rising sedentary life style, increasing healthcare spending, growing prevalence of chronic diseases, availability of advanced healthcare treatments and increasing awareness about schizoaffective disorders. While on the other hand, stringent regulatory approval procedures, social stigma associated with schizoaffective disorders, and lack of diagnosis at right time are some of the factors that are constraining the growth of the Latin America schizoaffective disorders treatment market.

The Latin America Schizoaffective Disorders Treatment market is segmented based on treatment into antipsychotics, mood stabilisers, antidepressants, anticonvulsants and psychotherapy. Antipsychotics is further segmented into aripriprazole, clozapine, haloperidol, risperidone, olanzapine and others. Aripripazole has the largest market share. Mood stabilisers are further divided into divalproex, lithium and others. Anticonvulsants are further categorised into valproate, carbamazepine and others. By antidepressants, the market is divided into desvenlafaxine, fluoxetine, escitalopram and others. Escitalopram has the largest share in the segment, which is followed by fluoxetine. Psychotherapy is further segmented into group therapy, psychotherapy & counselling and others.

The Latin America Schizoaffective Disorders Treatment market is divided based on geography into Argentina, Brazil, Chile, Peru and other parts of the region. Factors such as growing healthcare spending and rising prevalence of chronic diseases is expected to drive the market growth in the region.

Some of the major players in the market are Merz Pharma GmbH & Co. KGaA., Eli Lilliy and Company, Elan Pharmaceuticals, Ciba Pharmaceuticals, Abbott Pharmaceuticals, AstraZeneca plc, and Janssen-Cilag Pty Limited.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Treatment                                                  

                                5.1.1 Antipsychotics                                       

                                                5.1.1.1 Aripriprazole                       

                                                5.1.1.2 Clozapine                             

                                                5.1.1.3 Haloperidol                         

                                                5.1.1.4 Risperidone                        

                                                5.1.1.5 Olanzapine                          

                                                5.1.1.6 Others                   

                                5.1.2 Mood Stabilisers                                   

                                                5.1.2.1 Divalproex                           

                                                5.1.2.2 Lithium                  

                                                5.1.2.3 Others                   

                                5.1.3 Antidepressants                                   

                                                5.1.3.1 Desvenlafaxine                 

                                                5.1.3.2 Fluoxetine                           

                                                5.1.3.3 Escitalopram                       

                                                5.1.3.4 Others                   

                                5.1.4 Anticonvulsants                                    

                                                5.1.4.1 Valproate                             

                                                5.1.4.2 Carbamazepine                 

                                                5.1.4.3 Others                   

                                5.1.5 Psychotherapy                                      

                                                5.1.5.1 Group Therapy                  

                                                5.1.5.2 Psychotherapy & Counselling                      

                                                5.1.5.3 Others                   

                                5.1.6  Y-o-Y Growth Analysis, By Treatment                                         

                                5.1.7  Market Attractiveness Analysis, By Treatment                                       

                                5.1.8  Market Share Analysis, By Treatment                                        

                5.2 Cause of Disorder                                                    

                                5.2.1 Genetic Factors                                     

                                5.2.2 Chemical Factors                                  

                                5.2.3 Environmental Factors                                       

                                5.2.4 Y-o-Y Growth Analysis, By Cause of Disorder                                           

                                5.2.5 Market Attractiveness Analysis, By Cause of Disorder                                         

                                5.2.6 Market Share Analysis, By Cause of Disorder                                           

                5.3 Type                                                              

                                5.3.1 Manic Type                                             

                                5.3.2 Depressive Type                                   

                                5.3.3 Mixed Type                                            

                                5.3.4 Schizoaffective Disorders                                 

                                5.3.5 Y-o-Y Growth Analysis, By Type                                     

                                5.3.6  Market Attractiveness Analysis, By Type                                  

                                5.3.7  Market Share Analysis, By Type                                    

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Treatment                     

                                                6.1.3.2 By Cause of Disorder                       

                                                6.1.3.3 By Type                 

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Treatment                     

                                                6.1.4.2 By Cause of Disorder                       

                                                6.1.4.3 By Type                 

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Treatment                     

                                                6.1.5.2 By Cause of Disorder                       

                                                6.1.5.3 By Type                 

                6.2 Brazil                                                             

                6.3 Mexico                                                         

                6.4 Rest of Latin America                                                             

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Merz Pharma GmbH & Co. KGaA.                                                     

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Eli Lilliy and Company                                                             

                8.3 Elan Pharmaceuticals                                                              

                8.4 Ciba Pharmaceuticals                                                             

                8.5 Abbott Pharmaceuticals                                                        

                8.6 AstraZeneca plc                                                        

                8.7 Janssen-Cilag Pty Limited                                                     

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of region, by Treatmeant along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Schizoaffective Disorders Treatment  Market By Treatment , From 2018-2023 ( USD Million )
  2. Latin America Antipsychotics Market By Region, From 2018-2023 ( USD Million )
  3. Latin America Mood Stabilisers Market By Region, From 2018-2023 ( USD Million )
  4. Latin America Antidepressants Market By Region, From 2018-2023 ( USD Million )
  5. Latin America Anticonvulsants  Market By Region, From 2018-2023 ( USD Million )
  6. Latin America Psychotherapy Market By Region, From 2018-2023 ( USD Million )
  7. Brazil Schizoaffective Disorders Treatment  Market By Treatment , From 2018-2023 ( USD Million )
  8. Argentina Schizoaffective Disorders Treatment  Market By Treatment , From 2018-2023 ( USD Million )
  9. Mexico Schizoaffective Disorders Treatment  Market By Treatment , From 2018-2023 ( USD Million )
  10. Rest of Latin America Schizoaffective Disorders Treatment  Market By Treatment , From 2018-2023 ( USD Million )
Middle-East & Africa Cardiovascular Therapeutic Drugs By Disease (Arteriosclerosis, Cardiac Arrhythmias, Myocardial Infarction, Acute Coronary Syndrome, Peripheral Artery Disease, Coronary Artery Disease, Hypertensi...
Middle East And Africa Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail...
Latin America Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmaci...
Asia Pacific Clostridium Botulinum Market By Product (botulinum Toxin Type A And Botulinum Toxin Type B), By End User (aesthetic And Therapeutics), By Distribution Channel (hospitals, Clinics And Retail Pharmacies) ...
Europe Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmacies) And...
North America Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmaci...
Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmacies) And By Reg...
The Dental Bone Graft Substitutes Market Is Predicted To Reach USD 664.3 Million With A CAGR Of 9.8% According To Market Data Forecast Report....
Middle East And Africa Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal D...
Latin America Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Reg...
Asia-Pacific Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Rege...
Europe Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Regenerati...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.